Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$42K Buy
528
+4
+0.8% +$313 2.17% 14
2020
Q2
$38K Hold
524
3.13% 13
2020
Q1
$38K Buy
+524
New +$41.2K 3.97% 9
2015
Q2
Sell
-474
Closed -$26K 377
2015
Q1
$26K Buy
+474
New +$26.8K 0.03% 93

Other funds holding MRK

Ruggie Capital Group's MRK Position: Q3 2020 in Review

Ruggie Capital Group increased its Merck (MRK) stake by 0.76% in Q3 2020, buying an estimated $313 and bringing the position to 528 shares worth $42K. The position accounts for 2.17% of the portfolio, ranked #14.

Ruggie Capital Group first reported a position in MRK in Q1 2015 and has held it in 4 quarters since. 2,558 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

  • Ruggie Capital Group held 528 shares of Merck worth $42K as of Q3 2020.
  • Ruggie Capital Group bought 4 Merck shares in Q3 2020, an estimated $313.
  • Merck made up 2.17% of Ruggie Capital Group's portfolio in Q3 2020, its #14 holding.
  • Ruggie Capital Group first reported a position in Merck in Q1 2015 and has held it in 4 quarters since.
  • 2,558 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on Ruggie Capital Group's 13F filing for Q3 2020, filed 29 Oct 2020.